Resolve Biosciences empowers scientists with Molecular Cartography™ to gain new insights into spatial biology and advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, infectious disease, and agriculture.
Resolve Biosciences Read More »
ImmunoScape is a pre-clinical biotechnology company developing next-generation TCR cell therapies for cancer.
RVAC Medicines is a mRNA biopharmaceutical company that develops innovative mRNA vaccines and therapeutics for unmet medical needs.
Aspen Neuroscience combines stem cell biology with the latest artificial intelligence and genomic approaches to investigate patient-specific, restorative treatments.
Aspen Neuroscience Read More »
A technology-driven company that empowers transformative cell and gene therapies through an integrated technologies model, combining R&D platforms and process development for discovery and development of advanced therapeutics.
Now known as Standard BioTools Inc, Fluidigm’s technologies and products based on microfluidics and mass cytometry enable the exploration and analysis of individual cells, as well as the industrial application of genomics. Listed on NASDAQ in 2011.
A large-scale cell culture manufacturing site for the production of monoclonal antibodies and recombinant proteins. Acquired by Lonza Group in 2008.
Pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. Listed on NASDAQ in 2018.
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates to improve the quality of life and survival for people with cancer.
I-Mab is a full-stack biopharmaceutical company equipped to discover and develop best- and first-in-class biologics with global potential to treat cancer and auto-immune diseases.
I-MAB Biopharmaceutical Read More »
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.
